Stocks
Charles River Laboratories International, Inc.CRL
NYSEHealthcareBiotechnology$155.46+1.83%
A leading provider of essential research tools and integrated support services for drug discovery and development, Charles River Laboratories serves pharmaceutical and biotechnology clients globally. Investors monitor its performance as a bellwether for preclinical contract research demand and biopharma R&D spending trends.
Market Cap: $7.7B52W Range: $91.86 – $228.88
Congressional Interest in Charles River Laboratories International, Inc. (CRL)
11 members of Congress have disclosed 50 trades in Charles River Laboratories International, Inc. (CRL), a Healthcare company. The buy/sell breakdown shows 26 purchases versus 24 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
11
Buys
26
Sells
24
Who in Congress Is Trading CRL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-30 | Rohit Khanna | sell | $1K – $15K |
| 2026-02-05 | Rohit Khanna | sell | $1K – $15K |